Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 3
1965 1
1966 1
1968 1
1969 2
1970 1
1971 3
1972 2
1973 1
1974 1
1977 1
1978 2
1979 7
1980 4
1981 3
1982 1
1984 1
1985 6
1986 2
1988 1
1989 1
1990 1
1991 2
1993 1
1994 2
1995 3
1996 1
1998 1
1999 1
2001 1
2006 1
2007 4
2008 1
2011 1
2012 2
2013 1
2014 3
2015 3
2016 4
2017 4
2018 9
2019 16
2020 17
2021 8
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

126 results
Results by year
Filters applied: . Clear all
Page 1
Prostaglandin F2 alpha receptor.
Sakamoto K, Kamimura M, Kurozumi S, Ito S. Sakamoto K, et al. Among authors: kurozumi s. J Lipid Mediat Cell Signal. 1995 Oct;12(2-3):405-11. doi: 10.1016/0929-7855(95)00026-m. J Lipid Mediat Cell Signal. 1995. PMID: 8777582 Review. No abstract available.
Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer.
Honda C, Kurozumi S, Katayama A, Hanna-Khalil B, Masuda K, Nakazawa Y, Ogino M, Obayashi S, Yajima R, Makiguchi T, Oyama T, Horiguchi J, Shirabe K, Fujii T. Honda C, et al. Among authors: kurozumi s. Mol Clin Oncol. 2021 Dec;15(6):252. doi: 10.3892/mco.2021.2414. Epub 2021 Oct 8. Mol Clin Oncol. 2021. PMID: 34671471 Free PMC article.
Impact of muscle volume loss on acute oral mucositis in patients undergoing concurrent chemoradiotherapy after oral cancer resection.
Yamaguchi T, Makiguchi T, Nakamura H, Yamatsu Y, Hirai Y, Shoda K, Suzuki K, Kim M, Kurozumi S, Motegi SI, Shirabe K, Yokoo S. Yamaguchi T, et al. Among authors: kurozumi s. Int J Oral Maxillofac Surg. 2021 Sep;50(9):1195-1202. doi: 10.1016/j.ijom.2020.12.005. Epub 2021 Jan 4. Int J Oral Maxillofac Surg. 2021. PMID: 33414037
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer.
Katayama A, Miligy IM, Shiino S, Toss MS, Eldib K, Kurozumi S, Quinn CM, Badr N, Murray C, Provenzano E, Callagy G, Martyn C, Millican-Slater R, Purdie C, Purnell D, Pinder SE, Oyama T, Shaaban AM, Ellis I, Lee AHS, Rakha EA. Katayama A, et al. Among authors: kurozumi s. Mod Pathol. 2021 Jul;34(7):1271-1281. doi: 10.1038/s41379-021-00738-5. Epub 2021 Feb 1. Mod Pathol. 2021. PMID: 33526875 Free PMC article.
126 results